Clinuvel Pharmaceuticals Limited (AU:CUV) has released an update.
Clinuvel Pharmaceuticals Limited is inviting shareholders to its 2024 Annual General Meeting (AGM) on October 16, where important matters such as executive remuneration and board appointments will be discussed and voted upon. The event will be accessible both in person, in Melbourne, and via live stream, with the company recommending votes in favor of proposed remunerations and board changes, following a ‘first strike’ against the previous year’s remuneration report. Shareholders are encouraged to lodge their proxy votes online prior to the meeting and can submit questions in advance.
For further insights into AU:CUV stock, check out TipRanks’ Stock Analysis page.
